|
|
|
Insider
Information: |
Lloyd George W. |
Relationship: |
EVP, Investments & CLO |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
3,000 |
|
Indirect Shares
|
993,831 |
|
|
Direct
Value |
$84,570 |
|
|
Indirect Value
|
$28,016,096 |
|
|
Total
Shares |
996,831 |
|
|
Total
Value |
$28,100,666 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Royalty Pharma Plc |
RPRX |
EVP, Investments & CLO |
2023-11-13 |
3,000 |
2023-11-13 |
993,831 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2022-11-10 |
4 |
AS |
$43.85 |
$2,192,613 |
I/I |
(50,000) |
355,000 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2022-11-21 |
4 |
S |
$43.11 |
$1,018,719 |
I/I |
(23,631) |
351,900 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2022-11-22 |
4 |
S |
$43.14 |
$706,848 |
I/I |
(16,369) |
350,000 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-02-23 |
4 |
S |
$37.27 |
$931,658 |
I/I |
(25,000) |
325,000 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-03-28 |
4 |
S |
$37.06 |
$3,706,130 |
I/I |
(100,000) |
225,000 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-03-29 |
4 |
S |
$37.03 |
$473,165 |
I/I |
(12,779) |
212,221 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-06-02 |
4 |
S |
$33.54 |
$3,159,345 |
I/I |
(93,907) |
128,314 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-06-05 |
4 |
S |
$33.54 |
$644,446 |
I/I |
(19,215) |
109,099 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-06-06 |
4 |
S |
$33.82 |
$2,674,796 |
I/I |
(79,099) |
30,000 |
0 |
% |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
|
2023-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
150,000 |
220,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2020-06-18 |
4 |
B |
$28.00 |
$84,000 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2020-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
262,760 |
273,960 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2020-06-18 |
4 |
B |
$28.00 |
$313,600 |
I/I |
11,200 |
11,200 |
1.99 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2020-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
400,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-03-02 |
4 |
S |
$46.89 |
$5,867,148 |
I/I |
(125,000) |
300,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-03-22 |
4 |
S |
$46.32 |
$2,535,226 |
I/I |
(54,729) |
256,258 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-04-12 |
4 |
S |
$42.32 |
$19,002 |
I/I |
(449) |
255,898 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-04-14 |
4 |
S |
$42.12 |
$2,941,920 |
I/I |
(69,822) |
200,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,875,860 |
300,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-06-02 |
4 |
S |
$42.09 |
$2,632,513 |
I/I |
(62,500) |
1,050,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-06-04 |
4 |
S |
$44.69 |
$2,686,938 |
I/I |
(60,000) |
280,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-06-07 |
4 |
S |
$45.89 |
$5,676,228 |
I/I |
(122,500) |
260,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-06-08 |
4 |
S |
$46.47 |
$3,253,631 |
I/I |
(70,000) |
250,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-06-10 |
4 |
S |
$46.45 |
$3,254,369 |
I/I |
(70,000) |
240,000 |
0 |
- |
|
RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
|
2021-07-06 |
4 |
S |
$42.41 |
$1,549,145 |
I/I |
(36,530) |
849,697 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|